Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Director/PDMR Shareholding

26 Apr 2017 11:26

RNS Number : 4032D
Polypipe Group PLC
26 April 2017
 

Polypipe Group plc ('the Company')

Notification of Transaction by Persons Discharging Managerial Responsibilities

The Company announces that on 25 April 2017, an award under the Company's Deferred Share Bonus Plan ("DSBP") was granted over Ordinary Shares of £0.001 each ("Shares") as set out in the table below. The award was made in the form of a nil-cost option which is exercisable for 10 years from the date of grant, unless the exercise period is shortened in accordance with the DSBP rules.

 

 1. Name

 2. No. of Shares subject to DSBP

3. Exercise dates

 4. Lapse Dates

David Hall

23,924

25/04/2019 (50%)

25/04/2020 (50%)

25 April 2027

Martin Payne

8,241

25/04/2019 (50%)

25/04/2020 (50%)

25 April 2027

 

The award relates to the element of the 2016 Annual Bonus which is paid via the DSBP as set out in the 2016 Annual Report and Accounts which is available at www.polypipe.com.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated. 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Hall

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Nil-cost options granted as a Deferred Share Award on 25 April 2017, vesting on 25 April 2019 (50%) and 25 April 2020 (50%), exercisable for 10 years from the date of grant.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

23,924

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

N/A

f)

 

Place of the transaction

 

 

Outside of a Trading Venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Nil-cost options granted as a Deferred Share Award on 25 April 2017, vesting on 25 April 2019 (50%) and 25 April 2020 (50%), exercisable for 10 years from the date of grant.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

8,241

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

N/A

f)

 

Place of the transaction

 

 

Outside of a Trading Venue

 

Contacts:

Polypipe Group plc

David Hall, Chief Executive Officer

Martin Payne, Chief Financial Officer

Brunswick

Mike Smith

Will Rowberry

 

+44 (0) 1709 770 000

 

+44 (0) 20 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADBKBKDDQB
Date   Source Headline
17th Aug 201712:29 pmRNSHolding(s) in Company
8th Aug 20175:18 pmRNSDirector/PDMR Shareholding
8th Aug 20177:00 amRNSHalf-year Report
1st Aug 20174:22 pmRNSDirector Declaration
18th Jul 20179:49 amRNSHolding(s) in Company
6th Jul 20174:51 pmRNSHolding(s) in Company
4th Jul 201712:39 pmRNSHolding(s) in Company
3rd Jul 201711:19 amRNSTotal Voting Rights
28th Jun 20173:56 pmRNSHolding(s) in Company
28th Jun 20179:42 amRNSHolding(s) in Company
23rd Jun 20174:58 pmRNSHolding(s) in Company
14th Jun 20171:07 pmRNSHolding(s) in Company
13th Jun 20175:26 pmRNSHolding(s) in Company
7th Jun 20174:04 pmRNSHolding(s) in Company
25th May 201710:04 amRNSHolding(s) in Company
24th May 201711:28 amRNSResult of AGM
24th May 20177:00 amRNSDirectorate Change
24th May 20177:00 amRNSTrading Update
19th May 201711:35 amRNSHolding(s) in Company
3rd May 20179:48 amRNSDirector/PDMR Shareholding
28th Apr 20173:49 pmRNSHolding(s) in Company
26th Apr 201711:26 amRNSDirector/PDMR Shareholding
20th Apr 20177:30 amRNSAnnual Financial Report
30th Mar 20177:00 amRNSFinal Results
15th Feb 201710:40 amRNSHolding(s) in Company
3rd Feb 20174:20 pmRNSHolding(s) in Company
17th Jan 201710:53 amRNSHolding(s) in Company
6th Jan 20175:16 pmRNSHolding(s) in Company
6th Jan 20173:25 pmRNSHolding(s) in Company
2nd Dec 201612:55 pmRNSDirector/PDMR Shareholding
30th Nov 20164:35 pmRNSPrice Monitoring Extension
24th Nov 20164:25 pmRNSHolding(s) in Company
16th Nov 20169:06 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSTrading Update
4th Nov 20165:22 pmRNSHolding(s) in Company
3rd Oct 20165:37 pmRNSTotal Voting Rights
19th Sep 20161:13 pmRNSDirector/PDMR Shareholding
16th Sep 20164:08 pmRNSDirector/PDMR Shareholding
8th Sep 201610:44 amRNSTransaction in Own Shares
6th Sep 20162:44 pmRNSDirector/PDMR Shareholding
6th Sep 20162:43 pmRNSDirector/PDMR Shareholding
1st Sep 201610:04 amRNSTotal Voting Rights
31st Aug 20161:01 pmRNSHolding(s) in Company
30th Aug 20166:01 pmRNSTransaction in Own Shares
26th Aug 20165:18 pmRNSTransaction in Own Shares
26th Aug 201611:26 amRNSHolding(s) in Company
25th Aug 20165:32 pmRNSTransaction in Own Shares
24th Aug 20166:00 pmRNSTransaction in Own Shares
24th Aug 201611:20 amRNSHolding(s) in Company
23rd Aug 20166:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.